Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02677922
Title A Study to Assess the Safety and Efficacy of Two Combinations of Isocitrate Dehydrogenase (IDH) Mutant Targeted Therapies Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) Harboring IDH Mutations Who Are Not Candidates to Receive Intensive Induction Chemotherapy
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Celgene
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | SWE | NLD | ITA | GBR | FRA | ESP | DEU | CHE | CAN | BEL | AUS

Facility Status City State Zip Country Details
Local Institution - 105 Duarte California 91010-301 United States Details
Local Institution - 107 New Haven Connecticut 06510 United States Details
Local Institution - 108 Chicago Illinois 60611 United States Details
Local Institution - 103 Chicago Illinois 60637 United States Details
Local Institution - 102 Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02115 United States Details
Local Institution - 902 Boston Massachusetts 02115 United States Details
Local Institution - 106 New York New York 10065 United States Details
Local Institution - 110 Dallas Texas 75390-85520 United States Details
Local Institution - 178 Adelaide South Australia SA 5000 Australia Details
Local Institution - 175 Melbourne 3141 Australia Details
Local Institution - 177 Perth 6000 Australia Details
Local Institution - UNK-121 Yvoir 5530 Belgium Details
Local Institution - 125 Toronto Ontario M5G 2M9 Canada Details
Local Institution - 205 Lille 59037 France Details
Local Institution - 206 Marseille Cedex 9 13273 France Details
Local Institution - 200 Paris Cedex 10 75475 France Details
Local Institution - 204 Pessac 33604 France Details
Local Institution - 202 Pierre Benite 69495 France Details
Local Institution - 203 Toulouse 31059 France Details
Local Institution - 201 Villejuif CEDEX 94805 France Details
Local Institution - 227 Berlin 12200 Germany Details
Local Institution - 230 Dresden 01307 Germany Details
Local Institution - 225 Ulm 89081 Germany Details
Local Institution - 253 Bologna, Emilia-Romagna 40138 Italy Details
Local Institution - 252 Firenze 50134 Italy Details
Local Institution - 256 Genova 16132 Italy Details
Local Institution - 251 Orbassano 10043 Italy Details
Local Institution - 254 Padova 35128 Italy Details
Local Institution - 250 Pesaro 31122 Italy Details
Local Institution - 255 Roma 00189 Italy Details
Local Institution - 351 Seoul 135-710 Korea, Republic of Details
Local Institution - 350 Seoul 138-736 Korea, Republic of Details
Local Institution - 277 Utrecht 3584 CX Netherlands Details
Local Institution - 327 Lisboa 1169-050 Portugal Details
Local Institution - 379 Barcelona 08036 Spain Details
Local Institution - 375 Barcelona 08907 Spain Details
Local Institution - 376 Caceres 10005 Spain Details
Local Institution - 378 Madrid 28007 Spain Details
Local Institution - 381 Madrid 28033 Spain Details
Local Institution - 380 Malaga 29010 Spain Details
Local Institution - 377 Valencia 46009 Spain Details
Local Institution - UNK-52 Göteborg 413 45 Sweden Details
Local Institution - 403 Basel 4031 Switzerland Details
Local Institution - 401 Zurich 0 Switzerland Details
Local Institution - 429 Birmingham B15 2TH United Kingdom Details
Local Institution - 427 Headington OX3 9DU United Kingdom Details
Local Institution - 428 London SE5 9RS United Kingdom Details
Local Institution - 430 Sutton (Surrey) SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field